Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Hepatitis B vaccination in HIV-infected subjects.

Bongiovanni M, Casana M.

Curr Mol Pharmacol. 2008 Nov;1(3):191-4. Review.

PMID:
20021433
2.

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.

Laurence JC.

Am J Med. 2005 Oct;118 Suppl 10A:75S-83S. Review.

PMID:
16271546
3.

Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.

Potsch DV, Camacho LA, Tuboi S, Villar LM, Miguel JC, Ginuíno C, Silva EF, Mendonça RM, Moreira RB, Barroso PF.

Vaccine. 2012 Sep 7;30(41):5973-7. doi: 10.1016/j.vaccine.2012.07.028. Epub 2012 Jul 21.

PMID:
22828589
4.

Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.

Bailey CL, Smith V, Sands M.

Int J Infect Dis. 2008 Nov;12(6):e77-83. doi: 10.1016/j.ijid.2008.05.1226. Epub 2008 Aug 23.

5.

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

Cooper CL, Davis HL, Angel JB, Morris ML, Elfer SM, Seguin I, Krieg AM, Cameron DW.

AIDS. 2005 Sep 23;19(14):1473-9.

PMID:
16135900
6.

Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects.

Kellerman SE, Hanson DL, McNaghten AD, Fleming PL.

J Infect Dis. 2003 Aug 15;188(4):571-7. Epub 2003 Aug 5.

PMID:
12898445
7.

Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection.

Hadler SC, Judson FN, O'Malley PM, Altman NL, Penley K, Buchbinder S, Schable CA, Coleman PJ, Ostrow DN, Francis DP.

J Infect Dis. 1991 Mar;163(3):454-9.

PMID:
1825315
8.

Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.

Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C.

J Infect Dis. 2005 May 1;191(9):1435-41. Epub 2005 Mar 28.

PMID:
15809901
9.

High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.

Potsch DV, Oliveira ML, Ginuíno C, Miguel JC, Oliveira SA, Silva EF, Moreira RB, Cruz GV, Oliveira AL, Camacho LA, Barroso PF.

Vaccine. 2010 Feb 10;28(6):1447-50. doi: 10.1016/j.vaccine.2009.11.066. Epub 2009 Dec 6.

PMID:
19995540
10.

Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression.

Bunupuradah T, Ananworanich J, Pancharoen C, Petoumenos K, Prasitsuebsai W, Wongngam W, Ubolyam S, Sriheara C, Lange J, Phanuphak P, Puthanakit T.

Vaccine. 2011 Apr 5;29(16):2962-7. doi: 10.1016/j.vaccine.2011.01.114. Epub 2011 Feb 15.

PMID:
21329776
12.

[Efficacy of vaccination against hepatitis B in adult with HIV infection].

Kalinowska-Nowak A, Bociaga-Jasik M, Garlicki A, Mach T.

Przegl Epidemiol. 2007;61(2):339-47. Polish.

PMID:
17956052
13.

Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.

Pippi F, Bracciale L, Stolzuoli L, Giaccherini R, Montomoli E, Gentile C, Filetti S, De Luca A, Cellesi C.

HIV Med. 2008 Aug;9(7):519-25. doi: 10.1111/j.1468-1293.2008.00598.x. Epub 2008 Jun 28.

14.

Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.

Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T.

Am J Gastroenterol. 2008 Jan;103(1):138-46. Epub 2007 Oct 26.

PMID:
17970833
15.

Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection.

Liang SH, Chen TJ, Lee SS, Tseng FC, Huang CK, Lai CH, Chiou CP, Wang JL, Chung HC, Lin JN, Kuo YC, Lin HH.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):122-8. doi: 10.1097/QAI.0b013e3181daafd5.

PMID:
20386111
16.

The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.

Idilman R, De MN, Colantoni A, Nadir A, Van Thiel DH.

Am J Gastroenterol. 2002 Feb;97(2):435-9.

PMID:
11866284
17.

Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health.

Wilson CM, Ellenberg JH, Sawyer MK, Belzer M, Crowley-Nowick PA, Puga A, Futterman DC, Peralta L; Adolescent Medicine HIV/AIDS Research Network.

J Adolesc Health. 2001 Sep;29(3 Suppl):123-9.

PMID:
11530313
18.

Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule.

Wong EK, Bodsworth NJ, Slade MA, Mulhall BP, Donovan B.

Int J STD AIDS. 1996 Nov-Dec;7(7):490-4.

PMID:
9116065
19.

Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.

Young MD, Gooch WM 3rd, Zuckerman AJ, Du W, Dickson B, Maddrey WC.

J Med Virol. 2001 Jul;64(3):290-8.

PMID:
11424117

Supplemental Content

Support Center